Viatris resolves opioid-related claims for $335 mln; shares rise
Shares of the drug maker Viatris VTRS.O rise about 2.6% to $7.82 premarket
Co says would pay up to $335 mln over nine years as part of a nationwide settlement to resolve opioid related claims
VTRS to pay between $27.5 mln to $40 mln annually toward state and local opioid initiatives
As of last close, stock down 38.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

Gold Price Forecast: U.S.-Iran Tensions Ease, Nonfarm Payrolls Looming, What’s Next for Gold?

SpaceX IPO Approaches: Musk Dissolves xAI into SpaceX and Subleases 300MW Compute to Anthropic; Can the $2 Trillion Valuation Hold?

WTI and Brent Futures Both Fall Below $100 Mark, Have Oil Prices and Energy Sector Peaked?

Tradingkey








